J. Virally
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
J. Virally has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
M Mathieu
2 shared publicationsA. Elhadad
Service de Chirurgie thoracique et viscérale, Hôpital Robert Ballanger, Aulnay-Sous-Bois, France
1 shared publicationB Le Pecq-Gentil
Service de Pneumologie, Hôpital Robert Ballanger, Aulnay-sous-Bois
1 shared publicationB. Chalmin
Service d’Oncologie, Hôpital Robert Ballanger, Aulnay-Sous-Bois, France
1 shared publicationC Boiron
1 shared publicationC Lazzerini
1 shared publication
Latest Publications
- 28 February 2006
- Published by Elsevier in Revue des Maladies Respiratoires
- Vol. 23 (1) , 43-48
Épidémiologie et délais de prise en charge de 355 patients atteints de cancer bronchique
- 28 February 2006
- Published by Elsevier in Revue des Maladies Respiratoires
- Vol. 23 (1) , 43-48
Épidémiologie et délais de prise en charge de 355 patients atteints de cancer bronchique
- 1 November 2003
- Vol. 20, 683-9
[Home chemotherapy for lung cancer: a five year retrospective study].
We present the results of a five year retrospective study of chemotherapy delivered at home for patients suffering from non-small cell lung cancer. In partnership with "hospital at home" we have developed mechanisms to improve safety: secured prescriptions, treatments confirmations transmitted by fax, designed specific chemotherapy file and approval of family doctor prior to administration. We treated 74 patients and administered 401 injections of which 72% were for Vinorelbine and 28% for Gemcitabine. These protocols corresponded to day 8 injections for Cisplatin-based double drug therapies in 47% of cases and to weekly single drug chemotherapies in 53%. Constraints regarding medical staff availability were exceeded by many advantages: better hospital bed management, guaranteed treatment, improvements in patients' quality of life and strengthening of links between hospital and community.
- 1 November 2003
- Vol. 20, 683-9
[Home chemotherapy for lung cancer: a five year retrospective study].
We present the results of a five year retrospective study of chemotherapy delivered at home for patients suffering from non-small cell lung cancer. In partnership with "hospital at home" we have developed mechanisms to improve safety: secured prescriptions, treatments confirmations transmitted by fax, designed specific chemotherapy file and approval of family doctor prior to administration. We treated 74 patients and administered 401 injections of which 72% were for Vinorelbine and 28% for Gemcitabine. These protocols corresponded to day 8 injections for Cisplatin-based double drug therapies in 47% of cases and to weekly single drug chemotherapies in 53%. Constraints regarding medical staff availability were exceeded by many advantages: better hospital bed management, guaranteed treatment, improvements in patients' quality of life and strengthening of links between hospital and community.
- 25 April 1998
- Vol. 27 (16) , 779-85
[Risk factors in venous thromboembolism].